Medical Home Network, Labcorp collaboration harnesses data analytics to provide more comprehensive patient health picture

CHICAGO, July 8, 2021 - Medical Home Network (MHN) today announced a collaboration with Labcorp, a leading global life sciences company, to securely integrate lab results into patient records. The agreement will help MHN members within the Accountable Care Organization (MHN ACO) achieve better care and health at a lower cost for the more than 160,000 Medicaid safety net patients served by the MHN ACO.

Labcorp selected as a UnitedHealthcare preferred lab network provider for the third year in a row

Our continued participation in UnitedHeathcare’s Preferred Lab Network for 2021-2022 reflects our demonstrated commitment to provide high-quality, high-value laboratory services along with enhanced access, convenience and tools to help improve health and improve lives for millions of patients.

Labcorp to announce second quarter financial results on July 29, 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 2, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2021 before the market opens on Thursday, July 29, 2021 . The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Labcorp launches companion diagnostic for Amgen’s newly-approved lung cancer therapy

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2021-- Labcorp ® (NYSE: LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) who are eligible for treatment with LUMAKRAS™ (sotorasib), a new treatment option developed by Amgen .

Labcorp extends COVID-19 genomic sequencing work with the CDC

BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19. 

Labcorp adopts molecular loop SARS-CoV-2 research sequencing panel for large-scale viral surveillance

Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country.